Carcinosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Podcasts
• Clinical Trials

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Conditions:   Gynecologic Cancer;   Carcinoma;   Uterine Cancer;   Endometrial Cancer Intervention:   Drug: Cabo + Dostarlimab Sponsor:   University of Alabama at Birmingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2022 Category: Research Source Type: clinical trials